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Leishmania parasites are able to undergo apoptosis (programmed cell death), similarly to mammalian
cells. Recently it was demonstrated in vitro the anti-leishmanial effect of some natural and synthetic
stilbenoids including resveratrol and piceatannol. In this study we evaluated the Leishmanicidal activity
of a pool of stilbene derivatives which had previously shown high apoptotic efﬁcacy against neoplastic
cells. All the compounds tested were capable to decrease the parasite viability in a dose-dependent man-
ner. Trans-stilbenes proved to be markedly more effective than cis-isomers. This was different from that
observed in tumor cells in which cis-stilbenes were more potent cytotoxic agents. Trans-3,40,5-trimeth-
oxy-30-amino-stilbene (TTAS) was the most active stilbene showing in Leishmania infantum a LD50 value
of 2.6 lg/mL. In contrast TTAS showed a low toxicity when tested on normal hemopoietic cells. This com-
pound induced apoptosis in parasites by disrupting the mitochondrial membrane potential. Moreover it
shows the ability to block Leishmania parasites in G2–M phase of cell cycle in agreement with the data
obtained by afﬁnity chromatography that identify tubulin as the putative target of TTAS. In conclusion,
our results indicate that some stilbene derivatives are highly effective as anti-leishmanial agents and
TTAS represents a pro-apoptotic agent in Leishmania parasites that merit further in vivo investigation.
 2012 Elsevier Inc. All rights reserved.1. Introduction
Leishmaniasis are globally widespread parasitic diseases caused
by several protozoan parasites of the Leishmania genus. They arell rights reserved.
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, Interdepartmental Research
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eo).transmitted to humans by the bite of an insect vector, generally
the females sandﬂy of the genus Phlebotomus in the Old World,
or Luztomiya in the New World. Infections can vary from simple
cutaneous leishmaniasis (CL) to mucocutaneous (MCL) and visceral
leishmaniasis (VL) known as kala-azar, which is fatal if not treated.
It is estimated that about half a million people die annually with VL
and over 350 million people live at risk of this infection. Moreover,
AIDS and other immunosuppressive conditions enhanced the risk
of Leishmania-HIV co-infection and contribute to the appearance
of new severe clinical forms of the disease. To date, the greatest
38 M. Tolomeo et al. / Experimental Parasitology 133 (2013) 37–43prevalence of Leishmania-HIV co-infection has been in the Mediter-
ranean basin (Cruz et al., 2006; Colomba et al., 2009). Current
leishmaniasis treatment is based on chemotherapy, which relies
on a handful of drugs with serious limitations such as high cost
and toxicity, difﬁcult route of administration, and lack of efﬁcacy
in endemic areas (Murray et al., 2005; Croft et al., 2006; Baiocco
et al., 2009; Palumbo, 2009). Extensive evidence from studies in
animal models indicates that good protection can be achieved by
immunization, however, to date no vaccine is available and also
for this reason there is an urgent need to develop safer, cheaper
and more effective antileishmanial agents.
Natural products are potentially rich sources of novel active
molecules that may serve as lead or structural template for drug
discovery. In this context, in the last years several natural com-
pounds and their synthetic analogs have been tested against Leish-
mania, and many of them have demonstrated potential as
leishmanicidal agents (Changtam et al., 2010; Tipparaju et al.,
2008; Marin et al., 2009; Mishra et al., 2009a,b).
Stilbene-based compounds are widely represented in nature
(Shen et al., 2009), and have become of particular interest to chem-
ists and biologists because of their wide range of biological effects
including chemopreventive, antitumor, antioxidant, antimicrobial,
anti-inﬂammatory and antihistaminic activities (Hart, 1981; Fremont,
2000; Young and Chaplin, 2004). Recently, several natural and
synthetic stilbenoids have been studied for their leishmanicidal
properties (del Rey et al., 1999; del Olmo et al., 2001; Getti et al.,
2006), and some of them, including resveratrol (trans-3,40,5-tri-
hydroxystilbene) (Kedzierski et al., 2007) and piceatannol (trans-
3,30,40,5-tetrahydroxystilbene) (Duarte et al., 2008), have shown
anti-leishmanial activity in vitro.
In previous works, we have described the synthesis of a small li-
brary of cis- and trans-resveratrol based derivatives with the aim of
discovering new lead compoundswith anticancer potential (Roberti
et al., 2003). The best results were obtained with cis-3,40,5-trimeth-
oxy-30-hydroxy-stilbene 1 and its 30-amino derivative 2, which
showed pro-apoptotic activity at nanomolar concentrations in
HL60 leukemia cells. We have also demonstrated that pterostilbene
3 and 30-hydroxy pterostilbene 4 possess interesting antileukemic
properties and may constitute effective and powerful drugs in
MDR and apoptosis-resistant hematological malignancies. Notably,
the toxicity of these compounds, evaluated on normal hemopoietic
cells (CFU-GM), was very low (Tolomeo et al., 2005; Cao et al., 2008).
In light of the above, here we present a study in which we eval-
uated the anti-leishmanial activity of stilbenes 1–2,4 togheter with
their correspondent isomers 5–7 (1 vs 5, 2 vs 6, 4 vs 7, Table 1).
Moreover we tested the activity of pterostilbene 3.
Compound 6, namely trans-3,40,5-trimethoxy-30-amino-stilbene
(TTAS), was the most active derivative showing a LD50 value of
2.6 lg/mL. This ﬁnding prompted us to address the questions
regarding the cellular target and themolecularmechanismunderly-
ing the observed toxicity toward the parasite. To this endwe carried
out a chemical proteomic analysis that led us to the identiﬁcation of
tubulin as a putative target of TTAS.Moreover, from the loss inmito-
chondrial membrane potential in Leishmania parasite, we hypothe-
size the activation of mitochondrial apoptotic pathway.2. Materials and methods
2.1. Promastigote culture and cell treatments
The Leishmania infantum strain MON1/IPT1 promastigotes were
cultured in blood agar as previously described (Sengupta et al.,
1999). Brieﬂy, the cells were routinely maintained on solid blood
agar slants containing 1% glucose, 5.2% brain heart infusion agar
extract and rabbit blood (6% v/v) with gentamycin at a ﬁnal con-centration of 1–1.5 mg mL1 of medium at 25 C. Axenic amastig-
otes were obtained from promastigote cultures of Leishmania
infantum strain MON1/IPT1. Promastigotes growing in log phase
were harvested, washed in PBS, adjusted to a concentration of 106 -
parasites/mL in fresh medium at pH 5 and incubated at 32 C. Com-
plete transformation into amastigotes was achieved within 10 days
of incubation. For experimental purposes, exponentially growing
cells were collected and resuspended in RPMI medium supple-
mented with 10% fetal calf serum to achieve a culture density of
106 cells/mL. Cells were dispensed in 24-well culture plates and
appropriate concentrations of each compound were added.
2.2. Evaluation of live and dead parasites
To evaluate the leishmanicidal activity of stilbene-based com-
pounds the percentage of live and dead parasites was determined
morphologically after labeling with acridine orange (100 lg/mL)
and ethidium bromide (100 lg/mL). After 48 h exposure to each
compound, parasites (1  106) were centrifuged and the pellet
was resuspended in 25 lL of the dye mixture. Ten lL of the mix-
ture was examined in oil immersion with a 100 objective using
a ﬂuorescence microscope Nikon Eclipse E200. Live parasites were
determined by the uptake of acridine orange (green ﬂuorescence)
and exclusion of ethidium bromide (red ﬂuorescence). Dead para-
sites was determined by the uptake of ethidium bromide (red ﬂuo-
rescence). The percentage of parasite viability was determined
after counting at least 300 parasites.
2.3. Clonal assays
To evaluate the cytotoxic effects of stilbenes on normal hemo-
poietic progenitor cells, a clonal assay for CFU-GM (colony-forming
units-granulocyte macrophage) was performed. Bone marrow
mononucleated cells were obtained from bone marrow aspirates
of ﬁve normal volunteers. Bone marrow (3–5 mL) was diluted in
RPMI 1640, layered over a Ficoll-Hypaque gradient (density,
1.077), centrifuged at 400g for 30 min, and the interface mononu-
clear cells were collected. The interface cells were washed 3 times
in PBS, counted, and resuspended at a concentration of 1  105 in
MEM containing 0.9% methylcellulose, 30% FCS, 104 M beta-
mercaptoethanol, 5% medium conditioned by leukocytes in the
presence of phytohemagglutinin (PHA-LCM) in 15 mm plastic
dishes. After 7 days of culture at 37 C in an environment of 5%
CO2 and 100% humidity, the number of CFU-GM, was evaluated.
2.4. Flow cytometry analysis of cell cycle
Parasites were incubated for 24 h with the stilbene-based com-
pounds at 26 C. Afterward, the parasites were washed 3 times
with PBS containing 0.02 M EDTA to avoid clumps and were then
ﬁxed with cold methanol for 24 h. The parasites were resuspended
in 0.5 mL of PBS containing RNase I (50 lg/mL) and PI (25 lg/mL)
and were then incubated at 25 C for 20 min. The material was kept
on ice until analysis. The stained parasites were analyzed in a sin-
gle-parameter frequency histograms by using a FACScan ﬂow
cytometer (Becton Dickinson, San Jose, CA).
2.5. Determination of apoptosis by Annexin V
Externalization of phosphatidylserine on the outer membrane
of parasites with and without treatment was determined by using
Annexin V labeling kit following the manufacturer’s protocol (An-
nexin-V-FITC Apoptosis Detection Kit Alexis, Lausen, Switzerland)
(Singh et al., 2005). Brieﬂy, parasites (2  106) were washed with
PBS and centrifuged at 500g for 5 min. The pellet was suspended
in 100 lL of staining solution containing FITC-conjugated Annex-
Table 1
LD50 values (lg/mL) of stilbenes 1–7 against the Leishmania infantum strain IPT1.
Compounds Structure Promastigotes LD50 (lg/mL) Amastigotes LD50 (lg/mL)
1 17.5 ± 2.3 28.6 ± 3.4
2 18 ± 1.5 30.2 ± 4
3 7.6 ± 3 10.3 ± 1.8
4 6.5 ± 0.8 9.7 ± 2.1
5 10.9 ± 1.8 22.6 ± 3.9
6 (TTAS) 2.6 ± 0.4 4.3 ± 0.6
7 16.1 ± 3.2 28.4 ± 3.5
Pentostan 2.1 ± 0.5 8.3 ± 0.9
Values represent the mean ± SE for four independent experiments.
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Molecular Biochemicals, Mannheim, Germany) and incubated for
15 min at 20 C. Annexin V positive parasites were determined
by ﬂow cytometry (Becton Dickinson).2.6. Measurement of mitochondrial membrane potential
Mitochondrial transmembrane potential was investigated using
a JC-1 probe. JC-1 aggregates in mitochondria and ﬂuoresces red at
higher transmembrane potential but at lower transmembrane
potentials it cannot accumulate in the mitochondria and remains
as monomers in the cytoplasm that ﬂuoresce green. Brieﬂy, cells
were labeled for 10 min with 10 lM JC-1 (BD™ MitoScreen JC-1
Kit, BD Bioscences Pharmigen, San Diego, CA) at 37 C and washed
2 times. Multi-parameter ﬂow cytometry analysis was performed
by a Becton Dickinson ﬂow cytometer.2.7. Afﬁnity chromatography and identiﬁcation by mass spectroscopy
Compound 6 was immobilized via the primary amino group on
epoxi-activated agarose providing a 12-atoms spacer (1,4-bis(2:3-
epoxypropoxy)-butane). Swollen and thoroughly washed matrix
was resuspended in two volumes of 25–100 mM ligand dissolved
in 50% DMF/50 mM Na2CO3, 50 mM NaCl, pH 9.5. Coupling was
performed for 16 h at 25 C. After 5 washes with 50% DMF/
50 mM Na2CO3, 50 mM NaCl, pH 9.5, remaining reactive groups
were blocked with 1 M ethanolamine (pH 8) and thoroughlywashed with low/high pH buffers. A control matrix was prepared
without ligand and treated as described above. Direct absorbance
scans of the immobilized ligand on the matrix resuspendend in
50% glycerol solution (v/v) clearly conﬁrmed successful coupling
(data not shown). The amount of compound bound to the matrix
was determined by back calculation of amount of compound ap-
plied and amount recovered by UV determination. Routinely 50–
80 lmol/mL compound were bound. The resin was incubated in
2.5 volumes of Leishmania infantum total cell lysate (12 mg/mL
protein) at 4 C for 3 h. After washing with lysis buffer (4 times),
the matrix was heated at 95 C for 5 min with Laemmli sample buf-
fer, directly loaded and separated by 12% SDS–PAGE. Resolved pro-
teins were visualized by silver staining. The control matrix was
incubated with the same amount of lysate and treated equally. Pro-
tein bands were excise from the gels and fragments resulting from
trypsin digestion were analyzed by LC/ESI/MS/MS–QTOF mass
spectrometry. Data base searches were performed by using the
ProteinLynx Global Server (all species) and Mascot (all species)
search programs. A score >48 indicates identity (p < 0.05).3. Results
3.1. Cytotoxicity
Compounds 1–7 were tested for leishmanicidal activity against
promastigotes and amastigotes of Leishmania infantum (IPT1 strain).
Parasites were incubated in presence of different concentrations
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described in materials and methods. The sample concentration
causing 50% reduction in parasite viability (LD50) was used as the
parameter for leishmanicidal activity. LD50 values ranged from
18 lg/mL to 2.6 lg/mL in promastigotes and from 30.2 lg/mL to
4.3 lg/mL in amastigotes as depicted in Table 1. The cis-stilbene
derivatives were less active than their corresponding trans isomers
(compare 1 vs 5, 2 vs 6, 4 vs 7). The pterostilbene 3 showed an
activity comparable to that of its 30-hydroxy derivative 4. In the
present study the most active compound was trans-3,40,5-trimeth-Fig. 1. Morphologic changes observed in Leishmania infantum after exposure to
TTAS. Cells were exposed to a mixture of acridine orange and ethidium bromide as
described in Section 2. Live parasites were determined by the uptake of acridine
orange (green ﬂuorescence) and exclusion of ethidium bromide (red ﬂuorescence).
Dead parasites was determined by the uptake of ethidium bromide (red ﬂuores-
cence). (a) Control. (b) promastigotes exposed to 7 lg/mL TTAS for 48 h; parasites
uptake ethidium bromide showing a loss of volume and nuclear condensation. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
Fig. 2. Effects of compound TTAS on normal CFU-GM. Cells were exposed to
different concentrations of TTAS. The number of CFU-GM was calculated after
7 days of cell culture.oxy-30-amino-stilbene (6, TTAS) that showed a LD50 of 2.6 lg/mL
(Table 1). Compared to Pentostan (sodium stibogluconate) used
as reference compound, TTAS showed a slightly lower activity in
promastigotes but was more active in amastigotes (Table 1).
Parasites exposed 48 h to TTAS and stained with the acridine
orange and ethidium bromide mixture showed changes in
morphology (like loss of cell volume and nuclear condensation)
that shares many characteristics with metazoans apoptotic death
(Fig. 1).
In order to evaluate the toxicity of TTAS on normal hemopoi-
etic cells, bone marrow cells were treated with the compound
and the number of CFU-GM was evaluated after 7 days of culture
(Fig. 2). TTAS showed an IC50 on normal CFU-GM of 17.7 lg/mL,
more than 6 times higher than that showed on the Leishmania
infantum strain.
3.2. Cell cycle
The effect of TTAS on cell cycle distribution was analyzed in
Leishmania infantum. Cells were cultured in the presence of 7 lg/
mL of TTAS for 24 h. Flow cytometric analysis of cell cycle was car-
ried out after staining of parasites with propidium iodide. As
shown in Fig. 3, TTAS induced the arrest of Leishmanias prevalently
in G2–M phase of the cell cycle and an increase of the sub-G1 apop-
totic peak.
3.3. Determination of apoptosis by Annexin V
The Annexin V assay provides a simple and effective method to
detect apoptosis. This assay takes advantage on the fact that (i)
phosphatidylserine (PS) is translocated from the inner (cytoplas-
mic) leaﬂet of the plasma membrane to the outer (cell surface)
leaﬂet soon after the induction of apoptosis, (ii) the Annexin V pro-
tein has a strong and speciﬁc afﬁnity for PS.
As shown in Fig. 4, treatment of parasites with TTAS induces PS
externalization (increase of cells in the bottom right quadrant of
the ﬂow cytometric dot plot) indicating that the cause of parasite
death is the activation of apoptosis.
3.4. Mitochondrial membrane potential detection
TTAS induces change in mitochondrial membrane potential in
Leishmania infantum strain IPT1. Studies in a variety of blood, hepa-
tic, and immune cell models have shown that a fall in mitochon-
drial membrane potential is one of the earliest events in
apoptosis (Susin et al., 1998). In fact, opening of the mitochondrial
permeability transition pore has been demonstrated to induce
depolarization of the transmembrane potential, release of apopto-
genic factors and loss of oxidative phosphorylation. The loss of
mitochondrial membrane potential has been observed to play a
key role in drug-induced death in protozoans such as Leishmania
(Sen et al., 2004a,b).
In this study, the modiﬁcations in mitochondrial membrane po-
tential induced in Leishmania infantum strain IPT1, were evaluated
using the ﬂuorescent cationic dye JC-1. The JC-1 dye accumulates
in the mitochondria of healthy cells as aggregates, which are ﬂuo-
rescent red in color. Upon the onset of apoptosis, the mitochondrial
potential collapses and the JC-1 dye can no longer accumulate in
the mitochondria and remains in the cytoplasm in a monomeric
form which ﬂuoresces green. The differential distribution of the
red and green forms of the dye is easily analyzed by ﬂow cytome-
try. The dye is highly speciﬁc and sensitive and gives very little
background.
TTAS-induced loss in mitochondrial membrane potential in
Leishmania infantum strain IPT1 is demonstrated by the decrease
in red ﬂuorescence (FL2) in the cytoplasm (Fig. 5).
Fig. 3. Effects of compound TTAS on DNA content/parasite following treatment of Leishmania IPT1 strain for 24 h. The parasites were cultured without compound (control,
panel a) or with TTAS used at 7 lg/mL (panel b). Cell cycle distribution was analyzed by the standard propidium iodide procedure. G1, S, and G2–M cells are indicated in panel
a.
Fig. 4. Apoptosis evaluation by the Annexin-V test. Flow cytometric analysis of
apoptotic Leishmanias after 48 h treatment without (panel a) or with (panel b) TTAS
(7 lg/mL). Parasites were stained with Annexin V and propidium iodide. Cells in the
bottom right quadrant of each dot plot represent the percentage of cells in early
apoptosis (Annexin-V-positive and PI-negative). Data are representative of three
separate experiments.
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In order to isolate and identify the intracellular target of TTAS in
Leishmania infantum we decided to immobilize the compound and
to isolate its target(s) by an afﬁnity chromatography approach. The
SAR based on the LD50 values (Table 1) suggests that the addition of
a hydrogen bond donor/acceptor in meta position (4 vs 3) of the
phenyl moiety is not accompanied by a dramatic amelioration ofthe activity. Thus, it has been hypothesized that the stilbene scaf-
fold may represent the pharmacophore responsible for the activity.
In line with this hypothesis, TTAS has been chosen for performing
the afﬁnity chromatography because it guarantees a unique bind-
ing to the matrix via the primary amino group which react more
easily with the terminal epoxy group of the activated agarose then
hydroxyl groups (as in compounds 5), providing an uncharged,
hydrophilic and very stable 12-atoms spacer (Fig. 6). Direct absor-
bance scans of the immobilized ligand on the matrix resuspended
in 50% glycerol solution (v/v) conﬁrmed successful coupling (data
not shown). Routinely 50–80 lmol/mL were bound.
3.6. b-tubulin binds to the immobilized compound TTAS
The total parasite lysate was prepared, loaded into the matrices
and unbound material was removed as outlined in Section 2. The
bound proteins were separated by SDS–PAGE and visualized by sil-
ver-staining (Fig. 7). The compound TTAS-derived matrix led to the
detection of three distinct protein bands, two of which at higher
molecular weights also being present in the control (Fig. 7). Trypsin
digestion and peptide sequencing by LC/ESI/MS/MS–QTOF mass
spectrometry identiﬁed the speciﬁc band at 49 kDa as b-tubulin
of Leishmania infantum (expected size of 49.7 kDa; score 82),
whereas the other two correspondend to human keratin (scores
168 and 65). Human keratin that was present in both the control
matrix and the TTAS-derived matrix was the predominant contam-
ination which turned out to be present under any circumstances,
and it was even found in new batches of matrix that were stored
in sealed containers before ﬁrst use.4. Discussion
Leishmaniasis treatment is based on parenteral administration
of highly toxic drugs including pentavalent antimonials, amphoter-
icin B in its liposomal formulation (Ambisone) and pentamidine
(Murray et al., 2005; Croft et al., 2006; Baiocco et al., 2009; Pal-
umbo, 2009). Recently, oral administration of miltefosine has
emerged as an alternative approach (Herwaldt, 1999). It was ini-
tially identiﬁed as an anticancer drug and its antiprotozoal activity
was subsequently demonstrated against visceral and cutaneous
leishmaniasis. Unfortunately, despite its great efﬁcacy, miltefosine
is limited by its extremely long half-life, and low therapeutic index.
In view of the foregoing facts, there is an urgent need for the
development of antileishmania agents based on new molecular
scaffold endowed with improved efﬁcacy and lacking toxicity.
Recently, trans-resveratrol, a natural stilbene compound, has
been studied for its leishmanicidal properties. Resveratrol has
Fig. 5. Determination of TTAS-induced loss of mitochondrial potential in Leishmania infantum strain IPT1. Promastigotes treated with or without 7 lg/mL TTAS for 24 h were
stained with potentiometric probe JC-1 and change in ﬂuorescence were monitored by ﬂow cytometry. Green color (FL1) indicates monomer at low concentrations and red
color (FL2) indicates the aggregates at higher concentrations. JC-1 ﬂuorescence is seen in both the FL-2 and FL-1 channels (R1) in untreated parasites (a). There is a signiﬁcant
increase in the number of parasites with lowered red ﬂuorescence (R2) indicative of a change in the mitochondrial potential in parasites treated with TTAS (b). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article).
Fig. 6. Afﬁnity matrix preparation. Trans-3,40 ,5-trimethoxy-30-amino-stilbene 6 (TTAS) was coupled to epoxy-activated agarose consisting of a 12-atoms spacer (1,4-bis(2:3-
epoxypropoxy)butane) to form afﬁnity matrix. The agarose beads are shown as spheres.
Fig. 7. SDS–PAGE (12%) analysis of proteins reteined by the afﬁnity matrix.
Molecular mass marker (lane a). Samples of Leishmania infantum lysate (120 lg
total protein content) were incubated with control beads (lane b), or afﬁnity beads
(lane c). Proteins retained by the matrices were directly separated by SDS–PAGE.
Arrows indicate protein bands resulting from the compound derived matrices. K:
human keratin.
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major promastigotes (Kedzierski et al., 2007). Microscopic exami-
nation indicated that the effect was leishmanicidal rather than
leishmanistatic, as promastigote morphology indicated cells were
dead, rather than their growth was slowed down. This is interest-
ing considering that resveratrol is well-tolerated in vivo and it is no
toxic at doses 1000 times higher than a normal daily intake (Juan
et al., 2002). To obtain compounds endowed with higher antileish-
manial activity, new resveratrol derivatives have been synthesized
and tested on Leishmania parasites and normal human cells. How-
ever, most of them have shown a toxicity on normal ﬁbroblasts and
myeloid cells similar or higher than that observed in Leishmania
parasites (Kedzierski et al., 2007).
Previously we have described the synthesis of new cis- and
trans-resveratrol based derivatives with the aim of discovering
new lead compounds with anticancer potential (Roberti et al.,
2003; Tolomeo et al., 2005). In this work we investigated the
anti-leishmania activity of some of them, with the aim of discover-
ing new lead candidates or tools for the discovery of new therapeu-
tically relevant targets.
Therefore stilbene derivatives 1–7were assayed for their ability
to inhibit the growth of Leishmania infantum promastigotes and
amastigotes in vitro. All the compounds were capable to decrease
M. Tolomeo et al. / Experimental Parasitology 133 (2013) 37–43 43the parasite viability in a dose-dependent manner. As shown in Ta-
ble 1, the cis-stilbene derivatives 1, 2 and 7 showed an LD50 higher
than their correspondent trans-isomers 4, 5 and 6 both in prom-
astigotes and amastigotes. This was somewhat surprising to us be-
cause in our previous studies on leukemia cells, the cis-stilbene
derivatives showed higher cytotoxic and pro-apoptotic activity
than the parent trans-isomers (Roberti et al., 2003). The activity
of pterostilbene 3 (LD50 of 7.6 lg/mL) was comparable to that of
its 30-hydroxyl derivative 4 suggesting that the introduction of
the second hydroxyl function in meta position is not inﬂuencing
the leishmanicidal activity. Once again the result differed from that
previously obtained on leukemia cells where the above modiﬁca-
tion resulted in about 40-fold increase in both cytotoxic and pro-
apoptotic activity. In the present study the most active compound
was trans-3,40,5-trimethoxy-30-amino-stilbene (6, TTAS) that
showed a LD50 of 2.6 lg/mL. Of interest, this compound showed
an IC50 on normal CFU-GM of 17.7 lg/mL, therefore more than
6 times higher than that showed on the Leishmania infantum strain.
For this selectivity TTAS may be considered an interesting com-
pound for the antileishmanial therapy development, therefore we
tried to understand its antileishmanial mechanism of action. Leish-
mania parasites treated 24 h with TTAS were blocked prevalently
in G2–M phase of cell cycle and after 48 h of TTAS exposure Leish-
mania parasites were induced in apoptosis as shown by morpho-
logic examination and Annexin V positivity. The loss of
mitochondrial membrane potential suggests that the TTAS-in-
duced apoptosis is mediated by the mitochondrial apoptotic path-
way. To discover the main molecular target/s of TTAS in Leishmania
parasites we took advantage of a chemical proteomic approach
that was recently successfully applied by some of us (Kuettel
et al., 2009). Thus the amino-stilbene derivative TTAS, chosen
based on the presented activity data, was immobilized and the cor-
responding afﬁnity matrix was used to ﬁnd out potential targets.
Indeed this approach identiﬁed b-tubulin as putative speciﬁc target
of TTAS in Leishmania consistently with the ability of TTAS to block
Leishmania parasites in G2–M phase of cell cycle.Acknowledgment
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